Immunoglobulin single variable domains targeting PD-1

WO2026132542A2PCT designated stage Publication Date: 2026-06-25ABLYNX NV
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
ABLYNX NV
Filing Date
2025-12-19
Publication Date
2026-06-25

Smart Images

  • Figure EP2025088550_25062026_PF_FP_ABST
    Figure EP2025088550_25062026_PF_FP_ABST
Patent Text Reader

Abstract

The present technology provides polypeptides that binds to PD-1. The present technology also provides nucleic acids, vectors and compositions.
Need to check novelty before this filing date? Find Prior Art